At the European Congress of Radiology (ECR) 2024, Hologic, a leading force in women’s health, unveils groundbreaking AI research. Dr. Sarah M. Friedewald presents studies showcasing the prowess of Hologic’s Genius AI® Detection solution…
Continue Reading
Discover how Transpara Breast AI by ScreenPoint Medical revolutionizes mammography screening by providing radiologists with advanced support in cancer detection. Through real-world clinical studies presented at the European Congress of Radiology, learn how Transpara…
Continue Reading
The All India Institute Of Medical Science in New Delhi recently unveiled its new AI solution that assists with the early detection of cancer. Developed with the Centre for Development of Advanced Computing, Pune under the Ministry…
Continue Reading
What You Should Know:
– Freenome, a leader in blood-based early cancer detection, has raised $254M in a new funding round, fueled by its innovative multiomics platform and promising pipeline of tests. The funding was…
Continue Reading
Gary Frazier, Chief Growth Officer at Helio Genomics
What You Should Know:
– Helio Genomics, an AI-driven healthcare company specializing in diagnostics technology for cancer detection, has appointed Gary Frazier as its Chief Growth Officer.
– Frazier’s…
Continue Reading
What You Should Know:
Personalis, Inc., a leader in advanced genomics for cancer, and ClearNote Health, Inc., a pioneer in epigenomic technologies, today unveiled an alliance through which Personalis will expand its pharmaceutical service offerings by…
Continue Reading
By Shania Kennedy
January 30, 2024 – Researchers from City of Hope and its precision medicine research organization, the Translational Genomics Research Institute (TGen), have developed a machine learning (ML) approach that could facilitate the early…
Continue Reading
Explore AI’s evolution, challenges, and breakthroughs at RSNA23. Leaders, including Connie Lehman, MD, PhD, Etta D. Pisano, MD, and Fredrik Strand, MSc, MD, PhD, delve into clinical implementation challenges, cutting-edge research outcomes, and regulatory…
Continue Reading
Paige redefines cancer detection with a groundbreaking AI derived from the Virchow Pathology Foundation Model. This innovation spans over 17 tissue types, including rare tumors and metastatic deposits. By leveraging a vast repository of…
Continue Reading
What You Should Know:
– Veracyte, Inc. (Nasdaq: VCYT), a cancer diagnostics company acquires C2i Genomics, Inc., a pioneer in minimal residual disease (MRD) detection.
– Under the terms of the agreement, Veracyte will pay $70…
Continue Reading
